About
Mark Levin co-founded Third Rock Ventures in 2007, joining after more than 30 years of launching and building biotechnology companies. Before Third Rock, he co-founded Millennium Pharmaceuticals in 1993 and served as its chief executive officer; the company was later acquired by Takeda Oncology. At Third Rock, he focused on the formation, development, and strategic governance of the firm's portfolio companies. He met Third Rock co-founders Bob Tepper and Kevin Starr during his time at Millennium.
Invests in
BiotechHealthtechMedical Devices
Beyond investing
- Founded
- Co-founded Third Rock Ventures in 2007. Co-founded Millennium Pharmaceuticals in 1993, later acquired by Takeda Oncology.
- Education
- Earned an M.S. in Chemical Engineering and Biochemical Engineering from Washington University in St. Louis. Earned a B.S. from Washington University in St. Louis.
From Mark's own website — common ground for a warm intro.
Deals · 2
Fulcrum TherapeuticsBoard seat
via Third Rock Ventures · filed Jul 2017 · $55M raise
NinePoint MedicalBoard seat
via Third Rock Ventures · filed Nov 2015 · $40.7M raise
Attribution from SEC filings, press coverage, and firm rosters.